Introduction
Chemerin is a new chemotactic protein that recently joined the adipokines family. In 2007, it was discovered that chemerin and its receptor CMKLR1 are highly exaggerated in human and mouse adipocytes. This suggests that adipose tissue is a source and target for chemerin signaling [1] . Chemerin is a natural ligand for the chemerin receptor (ChemerinR), also known as chemokine receptor 1 [2, 3] . Also, chemerin is a chemoattractant composed of 163 amino acids and synthesized as pre-prochemerin once secreted as an inactive precursor, called prochemerin [3, 4] . The majority of circulating chemerin is in the form of inactive prochemerin and it has to be converted to bioactive chemerin isoforms (by proteolytic processes) for local biological activities [5] . Chemerin is excreted in the highest levels in the placenta, liver and white adipose tissue while it is excreted less in many tissues such as lung, brown fat tissue, heart, ovary, kidney, skeletal muscle and pancreas [3] . There is growing evidence that this newly discovered adipokine has been shown to play a role in adipogenesis and energy metabolism, including its role on obesity, Type 2 Diabetes Mellitus (T2DM), metabolic syndrome and cardiovascular diseases [3, 6, 7] . Determining circulating levels and monitoring the levels of chemerin adipokinin is of importance in relation to these diseases [8, 9] .
It has been suggested that probiotics, which are defined as living microorganisms with beneficial effects on the health of the host cell, may play a role in the prevention of obesity by various mechanisms and treatment of many diseases such as T2DM [10] . Despite the fact that obesity is a multi-factor etiology, changes in intestinal microbiology have attracted attention in recent years [11] . Probiotic reinforcement may be a promising treatment for reversing dysbiosis-related changes in obesity and related diseases [12] .
In this study, we aimed to evaluate the effects of probiotic supplementation of chemerin adipokines on serum levels and obesity markers in obese animal models produced by experimental high fat diet.
Material and methods
Within the scope of the study, 3 groups of experimental animals were formed. The first group was defined as the control group fed with the standard diet (Group 1), the second group as the group fed with the high fat diet (Group 2) and the third group as the group receive with probiotic capsule supplementation with a high fat diet (Group 3). After feeding the groups for a total of 12 week, in the obtained serum samples were examined with the effects of probiotic supplementation on HDL, LDL and total cholesterol which are indicators of lipid profile, leptin level which are the indicators of obesity, chemerin levels by used commercial ELISA (Rel Assay Diagnostic) kits. In addition, the weights of all rats were determined at the beginning of the study. Weights of all the rats in the groups will be weighed each week to monitor the obesity process and the relationship between the diets in different contents and Body Mass Index (BMI) were examined. The rats to be used in the study were obtained from Ondokuz Mayis University Experimental Animal Application and Research Center and the steps related to animal research are carried out in this center.
Results
Initial weights of the rats in the control and study groups, weight changes at the beginning and after the probiotic reinforcement are shown in Table I . The mean weights of the rats in Group 1, Group 2 and Group 3 were 240,200±9,67 g; 254,600 g±16,00 and 330,00±48,62 g, respectively. After feeding with 8-week high-fat diet of the rats in group 2 and group 3, the weights were increased to 307,00±14,50 g and 400,50±65,039 g, respectively. After 8 weeks of feding the BMI values of the rats in group 2 were reached from 0,44±0,27 g/cm 2 to 0.53±0. BMI changes in rats in group 2 are increasing rapidly, while changes in BMI in rats in group 3 tend to increase slowly after the start of probiotic supplementation. Table II summarizes the laboratory findings of the study rats at baseline and after 12 weeks of feeding. After 12-week high-fat diets, the rats in Group 2 had HDL levels of 21,00±2,63 μg/mL, LDL levels of 43,12±11,77 μg/mL and total cholesterol levels of 22,31 ± 3,99 mmol/L. The mean HDL, LDL and total cholesterol values of the rats in Group 3 after supplementation with probiotics were 23,32±3,76 μg/ mL, 31,87±2,89 μg/mL and 14,87±3,00 mmol/L, respectively. There was no significant difference between groups in terms of HDL and LDL, but a significant difference was found between total 
TABLE II. MEAN VALUES OF SERUM VALUES BY GROUPS

Discussion
It has been determined that the probiotic supplementation performed without any weight loss method has significant changes in both weight gain and metabolic parameters. Studies investigated in support of the association between adiposity and serum chemerin levels have observed significant reductions in serum chemerin levels compared to obese individuals who did not enter weight loss interventions (calori restriction or bariatric surgery) in individuals who various weight loss procedures [7, 13, 14] . Fatima et al. [15] also reported that circulating chemerin levels were significantly higher in obese subjects with BMI > 25 kg/m 2 than subjects with BMI <25 kg/ m 2 . In our study, chemerin levels of normal rats were found to be lower than those of obese rats.
In humans, serum chemerin concentration is significantly higher in the BMI and waist circumference than in normal weight patients [16] . In our study, a positive correlation was found between the BMI values and the chemerin levels of the rats.
When examinated of experimental animal studies suggests that probiotic supplementation results in similar results with our study on body weight and metabolic parameters. In a study evaluating changes in high fat diets-related adiposity, intestinal microbiota and serum metabolite levels in rats fed a balanced or high fat diet with and without probiotic for 8 weeks; it has been determined that probiotic supplementation modulates morphometric and metabolic parameters effectively and reduces body weight [11] .
Kang et al. [17] investigated the effects of probiotic supplementation on weight loss; rats were fed on a high carbohydrate diet for 12 weeks and received probiotic supplementation twice daily. This study in which changes in body weight and metabolic parameters are observed, shows that probiotics can prevent weight gain, improve metabolic parameters, and be an alternative method of treating obesity. In monosodium glutamate (MSG) -induced obese rats, probiotic supplementation similarly improves body weight and TC, LDL and HDL levels [18] .
Studies in the literature regarding the effect of probiotics on the serum level of chemerin adipokine are not sufficient and our results are of importance in terms of the reduced effect on chemerin adipokine levels.
Conclusion
As a result; this study showed that obese rats reduced the weight gain of probiotic supplementation without calorie restriction, positive effects on BMI and chemerin adipokine serum levels. The next step of our study is to increase the number of rats in the experimental groups and extend the probiotic supplementation period to achieve more comprehensive results.
